PT96852A - Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole - Google Patents

Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole

Info

Publication number
PT96852A
PT96852A PT96852A PT9685291A PT96852A PT 96852 A PT96852 A PT 96852A PT 96852 A PT96852 A PT 96852A PT 9685291 A PT9685291 A PT 9685291A PT 96852 A PT96852 A PT 96852A
Authority
PT
Portugal
Prior art keywords
tetrahydrobenz
aminocarbonyl
propyl
amino
indole
Prior art date
Application number
PT96852A
Other languages
English (en)
Other versions
PT96852B (pt
Inventor
Thomas Joseph Kress
David Lee Varie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT96852A publication Critical patent/PT96852A/pt
Publication of PT96852B publication Critical patent/PT96852B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT96852A 1990-02-26 1991-02-22 Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole PT96852B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48518590A 1990-02-26 1990-02-26

Publications (2)

Publication Number Publication Date
PT96852A true PT96852A (pt) 1991-10-31
PT96852B PT96852B (pt) 1998-07-31

Family

ID=23927224

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96852A PT96852B (pt) 1990-02-26 1991-02-22 Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole

Country Status (28)

Country Link
US (1) US5397799A (pt)
EP (1) EP0444852B1 (pt)
JP (1) JP3157007B2 (pt)
KR (1) KR100208114B1 (pt)
CN (1) CN1027503C (pt)
AT (1) ATE126506T1 (pt)
AU (1) AU629453B2 (pt)
BR (1) BR9100767A (pt)
CA (1) CA2037099C (pt)
CY (1) CY1887A (pt)
DE (1) DE69112099T2 (pt)
DK (1) DK0444852T3 (pt)
ES (1) ES2077796T3 (pt)
FI (1) FI95464C (pt)
GR (1) GR3017940T3 (pt)
HK (1) HK175495A (pt)
HU (1) HU217118B (pt)
IE (1) IE67801B1 (pt)
IL (1) IL97306A (pt)
LV (1) LV10251B (pt)
NO (1) NO174149C (pt)
NZ (1) NZ237181A (pt)
PT (1) PT96852B (pt)
RU (2) RU2034837C1 (pt)
SG (1) SG69975A1 (pt)
TW (1) TW219933B (pt)
YU (1) YU47594B (pt)
ZA (1) ZA911258B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz Úcd¾ indoles and process for the preparation of pure enantiomers thereof
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli 6-Substituted-hexahydrobenz (cd) indoles process for their preparation and pharmaceutical compositions containing them
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5648356A (en) * 1991-03-28 1997-07-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[CD]indoles
TW248556B (pt) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
UA53205C2 (en) * 2002-04-03 2006-06-15 Pharmatech Close Joint Stock C Antidepressant formulation and method for its manufacture
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
EP2044005B8 (en) * 2006-06-26 2012-12-05 Warner Chilcott Company, LLC Prolyl hydroxylase inhibitors and methods of use
ES2424122T3 (es) 2009-11-06 2013-09-27 Aerpio Therapeutics Inc. Inhibidores de la prolilhidroxilasa
NO2686520T3 (pt) 2011-06-06 2018-03-17
CA2837560C (en) 2011-06-06 2017-02-14 Akebia Therapeutics Inc. Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
HRP20240319T1 (hr) 2013-06-13 2024-05-24 Akebia Therapeutics, Inc. Pripravci i postupci za liječenje anemije
SG10202012791TA (en) 2013-11-15 2021-01-28 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
HK1247201A1 (zh) 2015-01-23 2018-09-21 阿克比治疗有限公司 2-(5-(3-氟苯基)-3-羟基吡啶甲醯胺)乙酸的固体形式、其组合物及用途
SI3277270T1 (sl) 2015-04-01 2022-04-29 Akebia Therapeutics, Inc. Sestavki in postopki za zdravljenje anemije
CA3097219A1 (en) 2018-05-09 2019-11-14 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles

Also Published As

Publication number Publication date
FI910895A0 (fi) 1991-02-25
JPH04217662A (ja) 1992-08-07
NO174149C (no) 1994-03-23
ATE126506T1 (de) 1995-09-15
LV10251B (en) 1995-04-20
CN1054589A (zh) 1991-09-18
IL97306A (en) 1996-10-16
BR9100767A (pt) 1991-10-29
NZ237181A (en) 1992-06-25
PT96852B (pt) 1998-07-31
ES2077796T3 (es) 1995-12-01
EP0444852A2 (en) 1991-09-04
SG69975A1 (en) 2000-01-25
AU629453B2 (en) 1992-10-01
CN1027503C (zh) 1995-01-25
KR910021375A (ko) 1991-12-20
HUT56542A (en) 1991-09-30
HU217118B (hu) 1999-11-29
JP3157007B2 (ja) 2001-04-16
GR3017940T3 (en) 1996-02-29
DK0444852T3 (da) 1995-12-11
IE910625A1 (en) 1991-08-28
RU2083561C1 (ru) 1997-07-10
IL97306A0 (en) 1992-05-25
FI95464C (fi) 1996-02-12
EP0444852A3 (en) 1992-02-19
FI95464B (fi) 1995-10-31
FI910895L (fi) 1991-08-27
ZA911258B (en) 1992-10-28
YU32791A (sh) 1994-01-20
CA2037099A1 (en) 1991-08-27
LV10251A (lv) 1994-10-20
US5397799A (en) 1995-03-14
EP0444852B1 (en) 1995-08-16
DE69112099D1 (de) 1995-09-21
HK175495A (en) 1995-11-24
IE67801B1 (en) 1996-05-01
YU47594B (sh) 1995-10-24
NO174149B (no) 1993-12-13
AU7197191A (en) 1991-08-29
NO910735L (no) 1991-08-27
KR100208114B1 (ko) 1999-07-15
CY1887A (en) 1996-04-05
TW219933B (pt) 1994-02-01
CA2037099C (en) 2001-09-11
DE69112099T2 (de) 1996-02-08
NO910735D0 (no) 1991-02-25
RU2034837C1 (ru) 1995-05-10

Similar Documents

Publication Publication Date Title
PT96852A (pt) Processo para a preparacao de um sal cristalino de 4-(di-n-propil)amino-6-aminocarbonil-1,3,4,5-tetra-hidrobenz{cd}indole
EG19122A (en) Process for preparing of -2- substituted oxindole derivatives
GB2187456B (en) Dyeing compoitions for keratinous fibres based on indole derivatives, and new compounds
DK29989A (da) Bifunktionelt vaekstmodulerende glycoprotein benaevnt amphiregulin
FI883744L (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia
ZA875690B (en) Apparatus for performing ophthalmic laser surgery
PT97906A (pt) Processo para a preparacao de novos derivados de tiofeno
GR871752B (en) Method for dying keratin fibres with indol derivatives combined withiodide salts
PT100041A (pt) Processo para a preparacao de derivados de indol e de composicoes farmaceuticas que os contem
RU92004575A (ru) Кристаллическая соль 4-(ди-н-пропил) амино-6-аминокарбонил-1,3,4,5-тетрагидробенз (cd) индола и ее 4p и 4s-изомеры
FI891700L (fi) Menetelmä beta-laktaamijohdannaisten valmistamiseksi
FI905536A7 (fi) Menetelmä N-glykosidijohdannaisten valmistamiseksi
MX9200793A (es) Tetrahidropirinas y metodo para su preparacion.
FI912163L (fi) Menetelmä substituoitujen indolien valmistamiseksi
GB2210287B (en) An apparatus and process for edge-defined, film-fed crystal growth
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
DE68900145D1 (de) Brillengestell-traeger fuer eine reproduzier-maschine.
AU590603B2 (en) A method of preparing indoles or indole derivatives, coupled via position 4, 5, 6, or 7, the indoles or indole derivatives concerned, as well as the use thereof
AU1741592A (en) Improved process for preparing benzenesulfonate salts
FI890658A7 (fi) Menetelmä 1,2-disulfoniyhdisteiden valmistamiseksi
KR900005865A (ko) 1,3,5-티아디아진-4-온 유도체의 제조방법
PT773220E (pt) 2-amino-6-cloropurina e metodo para a preparacao da mesma
EP0951815A3 (en) Flail cutter for brush cutting maching
NO921506D0 (no) Fremgangsmaate for opparbeiding av brukt-papir i naervaer avhydroksysulfonatsalter
ZA912473B (en) Epithelins:novel cysteine-rich growth modulating proteins

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910704

FG3A Patent granted, date of granting

Effective date: 19980408

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20071008